Skip to main content
. 2023 Aug 3;14:1201973. doi: 10.3389/fimmu.2023.1201973

Figure 2.

Figure 2

Evaluation of efficacy of BoHV-4-M-NSP5. The ability of BoHV-4-M-NSP5 immunization to confer protection was assessed following challenge infection of pigs with PRRSV-1 21301/19 (Study 1). The negative control group comprised two immunizations with BoHV-4 vector. PRRSV loads in the blood (A) and lungs (B) were inferred by RT-qPCR analysis of serum and BALF samples, respectively, and gross lung lesions (C) and lung histopathology (D; scores for 7 days post-challenge) were scored. Mean data ± SD are shown for (A), whereas for (B–D), data points represent individual pigs, with the median indicated by a horizontal line.